Clare Grieve

2PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Oct 22, 2024
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation.

Anita Kumar, Jacob Soumerai, Jeremy S Abramson

Pageof 1

Frequent Collaborators

2 joint publications

Anita Kumar

2 joint publications

Jeremy S Abramson

2 joint publications

Jeffrey A Barnes

2 joint publications

Ahmet Dogan